Matthew T. Wiley - Insider Trading & Ownership

Entity
Individual
Location
C/O Foamix Pharmaceuticals Ltd., 2 Holtzman St, Weizmann Science Park, Rehovot, Israel
Summary
The estimated net worth of Matthew T. Wiley is at least $264 K dollars as of June 18, 2024. Matthew T. Wiley is the Chief Commercial Officer of VYNE Therapeutics Inc. and owns shares of VYNE Therapeutics Inc. (VYNE) stock worth about $249 K. Matthew T. Wiley is the Chief Commercial Officer of BioXcel Therapeutics, Inc. and owns shares of BioXcel Therapeutics, Inc. (BTAI) stock worth about $14.8 K.
All Insider Reports
All Insider Reports

Ownership of Matthew T. Wiley

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
VYNE VYNE Therapeutics Inc. Chief Commercial Officer $249 K Jun 30, 2021
BTAI BioXcel Therapeutics, Inc. Chief Commercial Officer $14.8 K -$2.96 K -16.7% Jun 15, 2024

Insider Transactions Reported by Matthew T. Wiley:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership